Android app on Google Play

Analyst Sees Buying Opp in Coronado Biosciences (CNDO)

June 20, 2013 12:46 PM EDT Send to a Friend
Get Alerts CNDO Hot Sheet
Price: $1.88 +1.08%

Rating Summary:
    2 Buy, 5 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 9 | New: 0
Trade CNDO Now!
Join SI Premium – FREE
Wedbush today maintained an Outperform rating on Coronado Biosciences (NASDAQ: CNDO) with a price target of $13.00. Analyst Christopher N. Marai said he views recent weakness as a buying opportunity.

"We believe that recent weakness in CNDO is unfounded and creates an opportunity to own CNDO ahead of the next catalyst - data for TSO in Crohn's and psoriasis in H2:13. We see significant upside from current levels following positive Phase 2 read-outs in H2:13 (likely early fall time frame). Additionally, with positive data in Crohn’s, the Street is also likely value TSO in additional indications including MS, psoriasis and autism," said Marai.

For an analyst ratings summary and ratings history on Coronado Biosciences (NASDAQ: CNDO) click here. For more ratings news on Coronado Biosciences click here.

Shares of Coronado Biosciences closed at $8.12 yesterday.




You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View

Add Your Comment